Clinical Trial Update: Safety and Efficacy Study of Matrilin-3 Pretreated Autologous Adipose Derived Mesenchymal Stem Cells Implantation in Chronic Low Back Pain Patients With Lumbar Intervertebral Disc Degeneration [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial investigating autologous adipose-derived mesenchymal stem cell implantation for chronic low back pain due to lumbar disc degeneration; phase 1/2,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Low Back Pain Due to Degenerative Lumbar Disc Disease

Drugs mentioned

• Matrilin-3 pretreated autologous adipose-derived mesenchymal stem cells implantation

Snippet

Sponsor: Inbo Han | Conditions: Patients With Chronic Low Back Pain Due to Degenerative Lumbar Disc | Phase 1, Phase 2 | Status: UNKNOWN